Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Ophthalmology ; 125(6): e40-e41, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29784100
3.
Ophthalmology ; 125(2): 169-178, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28951074

RESUMEN

PURPOSE: To compare the accuracy of intraocular lens (IOL) calculation formulas (Barrett Universal II, Haigis, Hoffer Q, Holladay 1, Holladay 2, Olsen, and SRK/T) in the prediction of postoperative refraction using a single optical biometry device. DESIGN: Retrospective consecutive case series. PARTICIPANTS: A total of 13 301 cataract operations with an AcrySof SN60WF implant and 5200 operations with a SA60AT implant (Alcon Laboratories, Inc., Fort Worth, TX). METHODS: All patients undergoing cataract surgery between July 1, 2014, and December 31, 2015, with Lenstar 900 optical biometry were eligible. A single eye per patient was included in the final analysis, resulting in a total of 18 501 cases. We compared the performance of each formula with respect to the error in predicted spherical equivalent and evaluated the effect of applying the Wang-Koch (WK) adjustment for eyes with axial length >25.0 mm on 4 of the formulas. RESULTS: For the SN60WF, the standard deviation of the prediction error, in order of lowest to highest, was the Barrett Universal II (0.404), Olsen (0.424), Haigis (0.437), Holladay 2 (0.450), Holladay 1 (0.453), SRK/T (0.463), and Hoffer Q (0.473), and the results for the SA60AT were similar. The Barrett formula was significantly better than the other formulas in postoperative refraction prediction (P < 0.01) for both IOL types. Application of the WK axial length modification generally resulted in a shift from hyperopic to myopic outcomes in long eyes. CONCLUSIONS: Overall, the Barrett Universal II formula had the lowest prediction error for the 2 IOL models studied.


Asunto(s)
Biometría/métodos , Hiperopía/rehabilitación , Lentes Intraoculares , Miopía/rehabilitación , Óptica y Fotónica/instrumentación , Refracción Ocular/fisiología , Anciano , Femenino , Humanos , Hiperopía/fisiopatología , Masculino , Miopía/fisiopatología , Periodo Posoperatorio , Estudios Retrospectivos
4.
Ophthalmology ; 123(2): 287-294, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26459998

RESUMEN

PURPOSE: Intracameral injection is an effective method for preventing infection, but no controlled study has been published in the United States. DESIGN: We conducted an observational, longitudinal cohort study to examine the effect of topical and injected antibiotics on risk of endophthalmitis. PARTICIPANTS: We identified 315 246 eligible cataract procedures in 204 515 members of Kaiser Permanente, California, 2005-2012. METHODS: The study used information from the membership, medical, pharmacy, and surgical records from the electronic health record. MAIN OUTCOME MEASURES: The adjusted odds ratio (OR) and 95% confidence interval (CI) for the association of antibiotic prophylaxis (route and agent) with risk of endophthalmitis was estimated using logistic regression analysis. RESULTS: We confirmed 215 cases of endophthalmitis (0.07% or 0.7/1000). Posterior capsular rupture was associated with a 3.68-fold increased risk of endophthalmitis (CI, 1.89-7.20). Intracameral antibiotic was more effective than topical agent alone (OR, 0.58; CI, 0.38-0.91). Combining topical gatifloxacin or ofloxacin with intracameral agent was not more effective than using an intracameral agent alone (compared with intracameral only: intracameral plus topical, OR, 1.63; CI, 0.48-5.47). Compared with topical gatifloxacin, prophylaxis using topical aminoglycoside was ineffective (OR, 1.97; CI, 1.17-3.31). CONCLUSIONS: Surgical complication remains a key risk factor for endophthalmitis. Intracameral antibiotic was more effective for preventing post-cataract extraction endophthalmitis than topical antibiotic alone. Topical antibiotic was not shown to add to the effectiveness of an intracameral regimen.


Asunto(s)
Antibacterianos/uso terapéutico , Profilaxis Antibiótica , Endoftalmitis/prevención & control , Infecciones Bacterianas del Ojo/prevención & control , Facoemulsificación , Administración Tópica , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Aminoglicósidos/administración & dosificación , Aminoglicósidos/uso terapéutico , Antibacterianos/administración & dosificación , Cefalosporinas/administración & dosificación , Cefalosporinas/uso terapéutico , Bases de Datos Factuales , Endoftalmitis/epidemiología , Endoftalmitis/microbiología , Infecciones Bacterianas del Ojo/epidemiología , Infecciones Bacterianas del Ojo/microbiología , Femenino , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/uso terapéutico , Estudios de Seguimiento , Humanos , Inyecciones Intraoculares , Complicaciones Intraoperatorias/epidemiología , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...